News
J Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients ...
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
- New integration aligns U.S. operations, unifying RRD Biopharma Development, Uniphar Clinical, Diligent Health ...
FDA’s New Commissioner’s National Priority Voucher Program: A Game-Changer for Strategic Sponsors
The Opportunity Is Real—But So Are the Requirements
On June 17, FDA Commissioner Marty Makary announced the ...
RRD Biopharma Development to Attend BIO International Convention 2025
RRD Biopharma Development is excited to announce our participation in the BIO International Convention 2025, ...
The 505(b)(2) Platform Webinar Recording: “505(b)(2) Right-First-Time Strategy for Today’s FDA”
In today's dynamic regulatory environment, marked by potential organizational shifts and unpredictable timelines ...
RRD to Attend American Society of Clinical Oncology 2025
RRD Biopharma Development will be attending the 2025 ASCO Annual Meeting. We’re excited to engage with oncology ...
Cancer Drug Development Expert Eric Rowinsky, M.D., to Serve as Chief Medical Officer at RRD Biopharma Development, part of Uniphar
ROCKVILLE, Md., May 14, 2025 — RRD Biopharma Development (RRD), part of Uniphar, a specialized product development ...
RRD to Attend American Association for Cancer Research Annual Meeting
RRD Biopharma Development is attending the American Association for Cancer Research Annual Meeting and looking ...
RRD to Sponsor World Orphan Drug Congress 2025
RRD Biopharma Development is a proud Silver Sponsor of the World Orphan Drug Congress in Boston, April 22-24, ...
RRD is a Proud Sponsor of the 2025 Annual 505(b)(2) Platform Meeting
RRD Biopharma Development is proud to be a sponsor of the 505(b)(2) Platform Annual Meeting for 2025. We are ...
RRD to Attend RAPS Regulatory Strategy Conference
RRD Biopharma Development will be attending RAPS Regulatory Strategy Conference!
Where: Hilton Baltimore BWI ...
RRD to Attend Outsourcing in Clinical Trials West Coast
RRD Biopharma Development will be in San Francisco, CA for Outsourcing in Clinical Trials West, February 11-12, ...